Alexion, following clues from early tests, preps phase 3 study of Ultomiris in severe COVID-19

20th April 2020 Uncategorised 0

For about two months, Alexion has been exploring whether its Soliris—used to treat several rare diseases—might hold promise in treating patients with severe COVID-19, the illness caused by the novel coronavirus. But on Monday, the company said it was starting a phase 3 trial of Ultomiris, a similar medicine it launched last year. 

More: Alexion, following clues from early tests, preps phase 3 study of Ultomiris in severe COVID-19
Source: fierce